Publications

Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

 109
Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

Tags:

Previous Article

ALS drug effectively treats Alzheimer’s disease

Next Article

Inhibition of ceramide synthesis contributes to cardiometabolic diseases

Related Posts

Cystathionine γ-lyase is a major regulator of cognitive function through neurotrophin signaling and neurogenesis

Cystathionine γ-lyase is a major regulator of cognitive...

 51

Engineering the auxin-inducible degron system for tunable in vivo control of organismal physiology

Engineering the auxin-inducible degron system for tunab...

 45

Structural basis of apoptosis induction by the mitochondrial voltage-dependent anion channel

Structural basis of apoptosis induction by the mitochon...

 38